NFKB1 and cancer: Dysregulation of this pathway can lead to chronic inflammation and is implicated in various diseases, including cancer, where persistent NF-κB activation promotes tumourigenesis by facilitating epithelial-mesenchymal transition (EMT), angiogenesis, and immune evasion [43].